Evidence map›Paper›PMID 42806039›Full record

ArticleThe Journal of antibiotics2026

P450 cyptide synthase KwwB catalyzes non-native cross-link at Tyr-C3-Trp-N1 and tolerates leader peptide mutations.

Gaja Swarna Kumari, Abujunaid Habib Khan, Jabal Rahmat Haedar, Vic Kiselov, Viktors Romanuks, Gints Smits, Stefano Donadio, Chin-Soon Phan

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of antibiotics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gaja Swarna Kumari *National Institute of Research and Innovation, Riga, LV, 1006, Latvia.ORCID http://orcid.org/0009-0003-4545-6052
Abujunaid Habib Khan *National Institute of Research and Innovation, Riga, LV, 1006, Latvia.ORCID http://orcid.org/0009-0008-8086-5325
Jabal Rahmat HaedarNational Institute of Research and Innovation, Riga, LV, 1006, Latvia. jabal.rahmat.haedar@niri.lv.ORCID http://orcid.org/0009-0003-3080-8430
Vic KiselovNational Institute of Research and Innovation, Riga, LV, 1006, Latvia.
Viktors RomanuksNational Institute of Research and Innovation, Riga, LV, 1006, Latvia.
Gints SmitsNational Institute of Research and Innovation, Riga, LV, 1006, Latvia.ORCID http://orcid.org/0000-0001-5044-4169
Stefano DonadioNational Institute of Research and Innovation, Riga, LV, 1006, Latvia.ORCID http://orcid.org/0000-0002-2121-8979
Chin-Soon PhanNational Institute of Research and Innovation, Riga, LV, 1006, Latvia. csphan@mail.cgust.edu.tw.ORCID http://orcid.org/0000-0002-6500-696X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyptides refer to a rapidly growing class of ribosomally synthesized and post-translationally modified peptides (RiPPs) containing biaryl cyclophanes installed by P450 enzymes. Here, we further investigated P450 cyptide synthase KwwB from Kitasatospora sp. GAS204B, which expands the KwwB-catalyzed chemical repertoire to non-native cross-link between Tyr-C3 and Trp-N1 at the YxW motif. In addition, we demonstrated that KwwB tolerates leader peptide mutations at positions -11 through -2, with the exception of position -4, which contains a conserved Pro residue. This result provides an additional toolkit for cross-linked peptide modification.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.